Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Infectious diseases caused by bacteria, viruses, parasites, and fungi are a leading cause of global mortality, especially in low-income nations.
• Antimicrobial drugs have historically controlled infectious diseases, but rising antimicrobial resistance (AMR) threatens their efficacy, leading to untreatable infections.
• The emergence of drug-resistant pathogens necessitates the urgent development of novel antimicrobial agents.

Purpose of the Study:

• To review recent advancements in developing protein kinase inhibitors as potential antimicrobial drugs.
• To highlight the targeting of microbial and host protein kinases for novel therapeutic strategies.
• To focus on applications against significant infectious diseases including HIV, tuberculosis, and malaria.

Main Methods:

• Literature review of recent research on protein kinase inhibitors in antimicrobial drug development.
• Analysis of studies targeting both microbial and host protein kinases.
• Examination of efficacy against specific pathogens and diseases like HIV, tuberculosis, and malaria.

Main Results:

• Protein kinase inhibitors represent a promising class of novel antimicrobial drug candidates.
• Targeting protein kinases offers a viable strategy to combat drug-resistant microbes.
• Early research indicates potential applications against major infectious diseases.

Conclusions:

• Protein kinase inhibitors are an attractive area for developing new antimicrobials to address the challenge of resistance.
• Targeting host and microbial kinases provides new avenues for treating infections like HIV, tuberculosis, and malaria.
• Continued research is crucial for translating these findings into effective clinical treatments.